Effect of Hesperidin on Cardiovascular Disease Risk Factors: The Role of Intestinal Microbiota on Hesperidin Bioavailability.

Mas-Capdevila, Anna; Teichenne, Joan; Domenech-Coca, Cristina; Caimari, Antoni; Del Bas, Josep M; Escoté, Xavier; Crescenti, Anna

Mas-Capdevila, Anna; Teichenne, Joan; Domenech-Coca, Cristina; Caimari, Antoni; Del Bas, Josep M; Escoté, Xavier; Crescenti, Anna.

Affiliation

Mas-Capdevila A; Eurecat, Technology Centre of Catalunya. Nutrition and Health Unit, 43204 Reus, Spain.
Teichenne J; Department of Biochemistry and Biotechnology, Universitat Rovira i Virgili, Campus Sescelades,43007 Tarragona, Spain.
Domenech-Coca C; Eurecat, Technology Centre of Catalunya. Nutrition and Health Unit, 43204 Reus, Spain.
Caimari A; Eurecat, Technology Centre of Catalunya. Nutrition and Health Unit, 43204 Reus, Spain.
Del Bas JM; Eurecat, Technology Centre of Catalunya. Nutrition and Health Unit, 43204 Reus, Spain.
Escoté X; Eurecat, Technology Centre of Catalunya. Biotechnology Area and Technological Unit of Nutrition and Health, 43204 Reus, Spain.
Crescenti A; Eurecat, Technology Centre of Catalunya. Nutrition and Health Unit, 43204 Reus, Spain.

Nutrients ; 12(5)2020 May 20.

Article in En | MEDLINE | ID: mdl-32443766

Subject(s)
Key words

bioavailability; cardiovascular diseases; dysbiosis; gut microbiota; hesperetin; hesperidin

Fulltext

Add to My VHL

XML

PubMed Links

Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Cardiovascular Diseases / Gastrointestinal Microbiome / Hesperidin Type of study: Etiology_studies / Prognostic_studies / Risk_factors_studies Limits: Animals / Humans Language: En Journal: Nutrients Year: 2020 Document type: Article Affiliation country: España Country of publication: Suiza

Fulltext

Add to My VHL

XML

PubMed Links

Search on Google